Evidence map›Paper›PMID 24599455›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects.

Estefanía Moreno, David Moreno-Delgado, Gemma Navarro, Hanne M Hoffmann, Silvia Fuentes, Santi Rosell-Vilar, Paola Gasperini, Mar Rodríguez-Ruiz, Mireia Medrano, Josefa Mallol and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  3. Review
  4. Article
  5. Histamine HBiomolecules · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  12. Article
  13. Review
  14. Multi-Target Directed Ligands (MTDLs) Binding the σInternational journal of molecular sciences · 2021
    Review
  15. Histamine HBiological psychiatry · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Estefanía MorenoCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute of Biomedicine of the University of Barcelona (IBUB) and Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, 08028 Spain, Neuroscience Institute and Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitat Autónoma de Barcelona, 08193 Bellaterra, Spain, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, and School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, United Kingdom NR4 7TJ.
David Moreno-Delgado
Gemma Navarro
Hanne M Hoffmann
Silvia Fuentes
Santi Rosell-Vilar
Paola Gasperini
Mar Rodríguez-Ruiz
Mireia Medrano
Josefa Mallol
Antoni Cortés
Vicent Casadó
Carme Lluís
Sergi Ferré
Jordi Ortiz
Enric Canela
Peter J McCormick
Biomedical Research Networking Center on Neurodegenerative Diseases · ESUniversitat Autònoma de Barcelona · ESNational Institutes of Health · USUniversity of East Anglia · GB

Funding

Neurotransmitter Receptor Heteromers in the Striatal Spine ModuleZIADA000493 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI FERRE, SERGI · 2009 to 2025
$35.6M
Intramural NIH HHS
6 · The paper itself

Abstract

The general effects of cocaine are not well understood at the molecular level. What is known is that the dopamine D1 receptor plays an important role. Here we show that a key mechanism may be cocaine's blockade of the histamine H3 receptor-mediated inhibition of D1 receptor function. This blockade requires the σ1 receptor and occurs upon cocaine binding to σ1-D1-H3 receptor complexes. The cocaine-mediated disruption leaves an uninhibited D1 receptor that activates Gs, freely recruits β-arrestin, increases p-ERK 1/2 levels, and induces cell death when over activated. Using in vitro assays with transfected cells and in ex vivo experiments using both rats acutely treated or self-administered with cocaine along with mice depleted of σ1 receptor, we show that blockade of σ1 receptor by an antagonist restores the protective H3 receptor-mediated brake on D1 receptor signaling and prevents the cell death from elevated D1 receptor signaling. These findings suggest that a combination therapy of σ1R antagonists with H3 receptor agonists could serve to reduce some effects of cocaine.

Indexed as

AnimalsBenzamidesBenzazepinesCell Line, TumorCocaineCorpus StriatumDrug Delivery SystemsHEK293 CellsHumansMaleMiceMice, KnockoutOrgan Culture TechniquesProtein BindingRatsRats, Sprague-DawleyBenzamidesBenzazepinesCocainenemonaprideReceptors, Dopamine D1Receptors, Histamine H3Receptors, sigmaSCH 23390Sigma-1 Receptor

Identifiers

PMID24599455
PMCPMC3942573
OpenAlexW2085275470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.